傳媒專區
傳媒專區 > 媒體報導 > Lung cancer sufferers who don't smoke find help

Lung cancer sufferers who don't smoke find help

12-09-2014

 Lung cancer sufferers who don't smoke find help

Friday, September 12, 2014

The newly established ALK Lung Cancer Caring Group is advocating more help and attention for struggling patients.

The most effective treatment for anaplastic lymphoma kinase lung cancer is said to be targeted medication. However, such an approach comes at a high cost, ranging from HK$35,000 to HK$60,000 a month, for most patients.

ALK sufferers are usually non-smokers, with the lung cancer believed to be genetic.

Additionally, the group stresses that most patients require a lot of emotional support and counseling.

The median age for diagnosed ALK patients is 48.5 years, and coming down with cancer at that age affects their careers as well as family life. For example, a fourth-stage female patient, surnamed Chan, experienced huge financial and psychological burdens.

She suffered a great deal of stress and emotional trauma as a result of her illness. "Before seeking support from cancer groups, I was always depressed because I had the disease despite not being a smoker or drinker.""I could not afford targeted medication until recently because it is so expensive. The cost alone would exceed my salary, let alone my daily expenses," said Chan, who is 32 years old.

Patricia Poon Chu-mun, specialist in clinical oncology, said lung cancer due to genetic mutation often occurs in younger, non- smokers.

She said the median age for lung cancer sufferers is 66 and more than 90 percent of ALK patients are non-smokers.

BRIAN WONG

www.thestandard.com.hk/news_detail.asp

城中活動

2024-04-21 9:00 上午 小帆船體驗
2024-03-10 9:30 上午 Pink Run.HK 粉跑 2024

疑難排解

會員註冊


或許你會想看
政府公布「長者醫療券大灣區試點計劃」醫療機構名單(附圖)
政府今日(二月十九日)公布把七間位於粵港澳大灣區的醫療機構納入「長者醫療券大灣區試點計劃」,讓合資格的香港長者 […]
悟宿基金會攜手聖雅各福群會惠澤社房 推出「悟宿贈藥護基層」計劃
悟宿基金會攜手聖雅各福群會惠澤社區藥房 推出「悟宿贈藥護基層」計劃助抗癌母親添新春盼望 (香港,2024年2月 […]
「聽 ‧ 看 ‧ 療癒」創意藝術互動展覽 聽看青年心聲
你是否願意停下來,一秒、一分鐘、一小時,細看年青人的創作,聽聽他們的故事,挑戰、挫敗、情緒波動? 始於1994 […]
【香港大學深圳醫院】北上就診小貼士
最近經常收到同路人查詢,想去「香港大學深圳醫院」睇醫生~ 香港大學深圳醫院真係好大,早前小編同一眾同事好榮幸有 […]
當專科醫生成為專欄作者
當醫生又當作者的前輩後輩大有人在:他們有風趣幽默的,有學識淵博的,談的包括醫療專題不在話下,更有親子、武俠、科 […]
和黃醫藥宣布愛優特® (呋喹替尼) 於香港獲批用於治療轉移性結直腸癌
– 香港特區政府新的「1+」新藥審批機制下首個獲批在港註冊的藥物 ,為香港患者帶來重要的治療選擇 – – 愛優 […]
中大發現造血調節因子在腫瘤微環境的重要角色 為肺癌帶來新的治療靶點
肺癌是香港以至全球最致命的癌症之一,但目前缺乏有效的臨床治療。香港中文大學(中大)醫學院最新研究發現,肺癌能利 […]
肺癌治療新趨勢 術前加入免疫治療提升療效|心胸肺外科專科 薛高勇醫生
癌症是主要的疾病殺手之一,其中肺癌更一直蟬聯癌症殺手的首位。怎樣才能降低肺癌的殺傷力?其實只要愈早發現肺部病變 […]
推動香港與大灣區醫療融合 打造大灣區成為領先全球的健康生活灣區
【2024年1月20日,香港】大灣區醫療專業發展協會(以下簡稱「協會」)與香港恒生大學攜手合作,發展「未來智慧 […]
癌症資訊網慈善基金前往港大深圳醫院實地考察 支援粵港澳大灣區醫院管理局病人先導計劃(HA先導計劃)
中央頒布《粵港澳大灣區發展規劃綱要》至今5年,吸引了不少港人移居大灣區,為滿足日益殷切的大灣區港人醫療需求,香 […]
全港首個中文版網上「前列腺癌監察計算機」 助前列腺癌患者自行監察病情進展 與醫生共商最佳治療方案
前列腺癌發病率不斷攀升,現時佔本港男性最常見的癌症中排第三位,以及在致命癌症中排第四位。猶幸近年前列腺癌的治療 […]
【渣打香港馬拉松】 歡迎大家去嘉年華支持我哋呀!
相關文章: 3D影像呈現腫瘤 南韓醫界結合AR應用 眾籌計劃-耗盡積蓄為捉緊治療希望 (CIPSF-18003 […]